Jefferies analyst Andrew Tsai says a breakthrough in a skin‑cancer vaccine positions Moderna to have more than seven marketed products by 2027-28. He notes the company is diversifying into respiratory drugs, oncology and AI-designed therapeutics. Jefferies projects 2026 revenue could rise up to 10% from $1.9bn in 2025, which could allow Moderna to reach break-even in 2028. Successful trials of Moderna’s experimental mRNA cancer vaccine could drive sales growth beginning in 2027.

2026-08-20

Jefferies analyst Andrew Tsai says a breakthrough in a skin‑cancer vaccine positions Moderna to have more than seven marketed products by 2027-28. He notes the company is diversifying into respiratory drugs, oncology and AI-designed therapeutics. Jefferies projects 2026 revenue could rise up to 10% from $1.9bn in 2025, which could allow Moderna to reach break-even in 2028. Successful trials of Moderna’s experimental mRNA cancer vaccine could drive sales growth beginning in 2027.

其他消息
2026-08-20

亚股 1. 中国上证综指8月19日(周三)收盘下跌95.88点,跌幅:2.4%,报3894.42点; 2. 中国深证成指8月19日(周三)收盘下跌732.34点,跌幅:5.01%,报13890.15点; 3. 中国沪深300指数8月19日(周三)收盘下跌137.12点,跌幅:2.9%,报4588.7点; 4. 中国创业板指数8月19日(周三)收盘下跌232.07点,跌幅:6.26%,报3473.49点; 5. 中国科创50指数8月19日(周三)收盘下跌123.35点,跌幅:6.89%,报1667.52点; 6. 香港恒生指数8月19日(周三)收盘上涨23.92点,涨幅0.09%,报25495.07点; 7. 香港恒生科技指数8月19日(周三)收盘下跌57.13点,跌幅1.21%,报4682.05点。 欧股 1. 德国DAX30指数8月19日(周三)收盘下跌59.64点,跌幅0.23%,报26092.05点; 2. 英国富时100指数8月19日(周三)收盘上涨10.76点,涨幅0.10%,报10738.80点; 3. 法国CAC40指数8月19日(周三)收盘下跌7.45点,跌幅0.09%

2026-08-20

英国富时100指数8月20日(周四)开盘下跌9.10点,跌幅0.08%,报10734.25点; 法国CAC40指数8月20日(周四)开盘上涨1.63点,涨幅0.02%,报8503.54点; 欧洲斯托克50指数8月20日(周四)开盘下跌1.71点,跌幅0.03%,报6442.75点; 西班牙IBEX35指数8月20日(周四)开盘下跌21.13点,跌幅0.11%,报19826.37点; 意大利富时MIB指数8月20日(周四)开盘上涨43.80点,涨幅0.08%,报52662.00点; 德国DAX30指数8月20日(周四)开盘下跌61.28点,跌幅0.23%,报26068.5点。